Business Context and Reporting Period
This Form 8-K Current Report was filed by National Vision Holdings, Inc. on July 30, 2018. The filing discloses the completion of an underwritten public offering of common stock and the entry into a material definitive agreement.
Key Financial Metrics and Transaction Details
- Transaction Type: Underwritten offering of 14,447,698 shares of Common Stock.
- Offering Price: $38.2594 per share.
- Company Proceeds: The Company did not receive any proceeds from this offering; it was a sale by Selling Stockholders.
- Selling Stockholders: KKR Vision Aggregator L.P., Berkshire Fund VI, Limited Partnership, Berkshire Investors LLC, Berkshire Investors III LLC, and management selling stockholders.
- Underwriters: Merrill Lynch, Pierce, Fenner & Smith Incorporated, Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, and Jefferies LLC.
- Over-Allotment Option: Underwriters have a 30-day option to purchase an additional 2,167,154 shares.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transactional report rather than a periodic financial statement.
Material Changes
The primary material change is the completion of the secondary offering on July 30, 2018, resulting in a significant increase in the number of shares outstanding held by public investors, though the Company's capital structure regarding cash reserves remained unchanged by this specific transaction.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the Underwriting Agreement is incorporated by reference. The transaction was executed pursuant to Registration Statements on Form S-1 filed on July 23, 2018, and July 26, 2018.
Key Facts for Investor Verification
- Verify that the Company received zero proceeds from this specific offering, as it was a secondary sale by existing shareholders.
- Confirm the total number of shares sold (14,447,698) and the potential additional shares under the over-allotment option (2,167,154).
- Review the full Underwriting Agreement (Exhibit 1.1) for lock-up provisions and indemnification terms.
- Check subsequent filings to determine if the over-allotment option was exercised within the 30-day window.